Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.018 AUD | 0.00% |
|
0.00% | -48.57% |
05-22 | Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4% | MT |
05-20 | Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-48.57% | 10.32M | |
+16.49% | 122B | |
+21.73% | 115B | |
+20.76% | 26.64B | |
-21.81% | 19.91B | |
-16.89% | 16.32B | |
-44.74% | 15.52B | |
-18.81% | 15.49B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |
- Stock Market
- Equities
- CHM Stock
- News Chimeric Therapeutics Limited
- Chimeric Therapeutics Limited Appoints Dr. Yvonne Chen to Scientific Advisory Board